Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Byggfakta in connection with its listing on Nasdaq Stockholm
Mandate

Vinge has advised Byggfakta in connection with its listing on Nasdaq Stockholm

October 15, 2021 Banking and Finance Capital Markets and Public M&A M&A Corporate Tax Intellectual Property IT, Telecommunications and Outsourcing Employment and Benefits

The first day of trading on Nasdaq Stockholm large cap was 15 October 2021. The offer price was SEK 75 per share, equivalent to a market value for the Byggfakta Group of approximately SEK 16.4 billion. The offer covers 64,483,197 shares together with an oversubscription option to a total value of approximately SEK 5.5 billion.

Byggfakta Group, with its registered office in Ljusdal, Sweden, and dating back to 1936, is a leading digital platform which offers solutions which match actors in the building industry’s value chain, maximizes sales and improves efficiency for its customers.

Vinge’s team primarily consisted of Anders Strid, Rikard Lindahl, Edin Agic, Lina André, Linus Adolfsson, David Bokliden, Adrian Filipovic and Jacob Benzow (Capital Markets and Public M&A), Magnus Pauli (M&A), Albert Wållgren, Linn Adelwald, Ludvig Wettergren (Banking and Finance), Maria Schultzberg, Victor Ericsson and Emelie Svanberg (Tax), Anna-Maria Lagerqvist Gahm, Anna Högsten and Stina Karinsdotter (IP/IT), Rebecka Hansson (Employment) and Viktoria Owetz Leyva and Nathalie Hughes (VDR).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025